Antimalarial activity of natural, racemic and unnatural dihydroquinine, dihydroquinidine and their various racemic analogs in mice infected with Plasmodium berghei.
D000284:Administration, Oral; D000818:Animals; D000962:Antimalarials / Q000627:therapeutic use* / Q000633:toxicity; D007274:Injections, Intraperitoneal; D007928:Lethal Dose 50; D008288:Malaria / Q000188:drug therapy*; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D008826:Microbial Sensitivity Tests; D010961:Plasmodium / Q000187:drug effects; D011802:Quinidine / Q000627:therapeutic use* / Q000633:toxicity; D011803:Quinine / Q000627:therapeutic use* / Q000633:toxicity; D013237:Stereoisomerism
D000962:Antimalarials; D011803:Quinine; D011802:Quinidine